<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>NewsTin - Medical Branches</title>
    <link>http://www.newstin.com/us/MEDICAL_BRANCHES</link>
    <description>Global Social News Platform</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Eisai's Commitment to Oncology Demonstrated By Clinical Data to Be Presented at ASCO Annual Meeting</title>
      <link>http://www.newstin.com/tag/us/57487434</link>
      <description>WOODCLIFF LAKE, N.J., May 15 /PRNewswire/ -- Eisai Corporation of North America announced today that results from 16 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th...</description>
      <pubDate>Fri, 16 May 2008 05:00:05 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57487434</guid>
      <dc:date>2008-05-16T05:00:05Z</dc:date>
    </item>
    <item>
      <title>Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve...</title>
      <link>http://www.newstin.com/tag/us/57439451</link>
      <description>Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting - Updated Phase II results with Tasigna(R) in Philadelphia chromosome-positive chronic myeloid leukemia to be presented...</description>
      <pubDate>Thu, 15 May 2008 20:15:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57439451</guid>
      <dc:date>2008-05-15T20:15:00Z</dc:date>
    </item>
    <item>
      <title>Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant...</title>
      <link>http://www.newstin.com/tag/us/57482145</link>
      <description>Posted on: Thursday, 15 May 2008, 21:00 CDT SAN FRANCISCO, May 15 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that data from an ongoing Phase 1-2 clinical trial of its novel androgen receptor antagonist, MDV3100, will be presented in an oral presentation at the 44th American...</description>
      <pubDate>Fri, 16 May 2008 02:00:06 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57482145</guid>
      <dc:date>2008-05-16T02:00:06Z</dc:date>
    </item>
    <item>
      <title>Dr. Jay Gordon Speaks Out at the Whole Children, Whole Planet Expo</title>
      <link>http://www.newstin.com/tag/us/57443305</link>
      <description>Dr. Jay Gordon, nationally recognized pediatrician and an outspoken advocate for the reexamination of the safety and efficacy of childhood vaccinations, will appear as a guest speaker at the Whole Children, Whole Planet Expo (WCWP) at Highland Hall Waldorf School in Northridge. Dr.</description>
      <pubDate>Thu, 15 May 2008 20:00:45 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57443305</guid>
      <dc:date>2008-05-15T20:00:45Z</dc:date>
    </item>
    <item>
      <title>First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System</title>
      <link>http://www.newstin.com/tag/us/57443326</link>
      <description>Posted on: Thursday, 15 May 2008, 15:00 CDT BURLINGTON, Mass., May 15 /PRNewswire/ -- InfraReDx, Inc. today announced that physicians at Beaumont Hospital in Royal Oak, Mich., have successfully used its LipiScan(TM) Coronary Imaging System in a patient undergoing a cardiac catheterization. The...</description>
      <pubDate>Thu, 15 May 2008 20:00:45 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57443326</guid>
      <dc:date>2008-05-15T20:00:45Z</dc:date>
    </item>
    <item>
      <title>CerviLenz Receives JumpStart Investment</title>
      <link>http://www.newstin.com/tag/us/57466763</link>
      <description>CLEVELAND, May 15 /PRNewswire/ -- JumpStart Inc., the Northeast Ohio venture development organization that accelerates the growth of innovative early-stage businesses and ideas, has announced an investment commitment of $350,000 in CerviLenz(TM), Inc.</description>
      <pubDate>Thu, 15 May 2008 23:00:37 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57466763</guid>
      <dc:date>2008-05-15T23:00:37Z</dc:date>
    </item>
    <item>
      <title>Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual...</title>
      <link>http://www.newstin.com/tag/us/57482226</link>
      <description>ABBOTT PARK, Ill., May 15 /PRNewswire-FirstCall/ -- Abbott scientists will highlight the latest clinical trial data of several investigative compounds in the company's oncology pipeline at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled for May 30 in Chicago.</description>
      <pubDate>Fri, 16 May 2008 02:00:06 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57482226</guid>
      <dc:date>2008-05-16T02:00:06Z</dc:date>
    </item>
    <item>
      <title>Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American...</title>
      <link>http://www.newstin.com/tag/us/57482184</link>
      <description>Posted on: Thursday, 15 May 2008, 21:00 CDT SOUTH SAN FRANCISCO, Calif., May 15 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that the Company will present data from three clinical trials of picoplatin, in various tumor...</description>
      <pubDate>Fri, 16 May 2008 02:00:06 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57482184</guid>
      <dc:date>2008-05-16T02:00:06Z</dc:date>
    </item>
    <item>
      <title>Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound...</title>
      <link>http://www.newstin.com/tag/us/57437631</link>
      <description>Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced...</description>
      <pubDate>Thu, 15 May 2008 20:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57437631</guid>
      <dc:date>2008-05-15T20:00:00Z</dc:date>
    </item>
    <item>
      <title>Cancer Research Group Releases Data</title>
      <link>http://www.newstin.com/tag/us/57485100</link>
      <description>To curtail data leaks that can affect drugmakers' stock prices, the American Society of Clinical Oncology discloses trial outcomes before its annual meeting Studies of drugs that may stop the spread of many cancers—vaccines for brain tumors, treatments that prevent bone metastases, vitamins that...</description>
      <pubDate>Fri, 16 May 2008 04:01:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/57485100</guid>
      <dc:date>2008-05-16T04:01:00Z</dc:date>
    </item>
  </channel>
</rss>

